NEO
Neogenomics Inc
Price:  
16.40 
USD
Volume:  
458,300.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO WACC - Weighted Average Cost of Capital

The WACC of Neogenomics Inc (NEO) is 7.5%.

The Cost of Equity of Neogenomics Inc (NEO) is 8.30%.
The Cost of Debt of Neogenomics Inc (NEO) is 5.50%.

Range Selected
Cost of equity 7.00% - 9.60% 8.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.2% - 8.7% 7.5%
WACC

NEO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.69 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 9.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.26 0.26
Cost of debt 4.00% 7.00%
After-tax WACC 6.2% 8.7%
Selected WACC 7.5%